Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search

Janssen Biotech

Janssen Biotech is a biotechnology company founded in 1979.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
May 30, 2021
The Times of India
Science News: The US Food and Drug Administration on February 27 this year issued an emergency use authorization (EUA) for the vaccine for the prevention of Covid-1.
May 21, 2021
BioSpace
RYBREVANTTM (amivantamab-vmjw) Receives FDA Approval as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations - read this article along with other careers information, tips and advice on BioSpace
Janssen Pharmaceutical Companies of Johnson & Johnson
May 21, 2021
www.prnewswire.com:443
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has granted the...
May 19, 2021
BioSpace
Updated Amivantamab and Lazertinib Combination Data Demonstrate Durable Responses and Clinical Activity for Osimertinib-Relapsed Patients with EGFR-Mutated Non-Small Cell Lung Cancer - read this article along with other careers information, tips and advice on BioSpace
Janssen Pharmaceutical Companies of Johnson & Johnson
May 19, 2021
www.prnewswire.com:443
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated data from the Phase 1 CHRYSALIS study showing treatment with...
SHOW MORE

References

Golden logo
By using this site, you agree to our Terms & Conditions.